Search Knowledge Base

1 result for "dual-anti-platelet-therapy"

Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention pubmed_article
Evidence Source 2020 PMID: 32779497

Evidence Search Results semantic · quality-ranked

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders meta_analysis cochrane_review
Quality: 80 2026 PMID: 41670018 DOI: 10.1002/14651858.CD009733.pub4
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome meta_analysis pubmed_article
Quality: 77 2020 PMID: 33045766 DOI: 10.1002/14651858.CD012169.pub3
Direct oral anticoagulants vs vitamin K antagonists in patients with single- or double-positive antiphospholipid syndrome: a systematic review and meta-analysis meta_analysis pubmed_article
Quality: 67 2025 PMID: 40370130 DOI: 10.20452/pamw.17006
Efficacy and safety of non-vitamin K antagonist oral anticoagulants combined with antiplatelet drugs for patients with peripheral artery disease: A systematic review and meta-analysis of randomized controlled trials meta_analysis pubmed_article
Quality: 65 2022 PMID: 33759649 DOI: 10.1177/17085381211003694
Antiplatelet agents and anticoagulants for hypertension systematic_review pubmed_article
Quality: 76 2022 PMID: 35900898 DOI: 10.1002/14651858.CD003186.pub4
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis meta_analysis pubmed_article
Quality: 63 2022 PMID: 35867933 DOI: 10.1097/MBC.0000000000001153
Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention meta_analysis pubmed_article
Quality: 51 2020 PMID: 32779497 DOI: 10.1161/JAHA.120.017109
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome meta_analysis pubmed_article
Quality: 78 2017 PMID: 28968483 DOI: 10.1002/14651858.CD012169.pub2
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders meta_analysis cochrane_review
Quality: 72 2016 PMID: 26978005 DOI: 10.1002/14651858.CD009733.pub3
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism meta_analysis pubmed_article
Quality: 74 2017 PMID: 29244199 DOI: 10.1002/14651858.CD011088.pub2

View full evidence search →